The post Abercrombie & Fitch Goes Western With Kemo Sabe Brand Collaboration appeared on BitcoinEthereumNews.com. Models wearing the new A & F X Kemo Sabe collection. Photo Courtesy of Abercrombie & Fitch While the brand collaboration can be traced back to 1924 when Château Mouton Rothschild commissioned Jean Carlu to design a wine bottle label, the modern-day collaboration which merged when Nike teamed up with Commes Des Garcons, hit a pivotal moment when H&M released its first designer collaboration with Karl Lagerfeld. Since then, the mutual benefit that mass audience brands and specialty luxury brands can garner from one another is undeniable. Such is the case with a new partnership between Abercrombie & Fitch and Kemo Sabe, the cult-status luxury Western-centric accessories and outwear store that was founded in Aspen, CO. in 1990. The offering Abercrombie X Kemo Sabe offering, which features twelve women’s clothing styles and three accessories’ styles will launch October 30th on online at Abercrombie.com and all stores globally November 6th. The collection debuted in Manhattan a few weeks in advance to press at a presentation held at Common Country bar where Corey Robinson, chief product officer of Abercrombie & Fitch Co. and Wendy Kunkle, President and Owner of Kemo Sabe were on hand to discuss the unique pair up. A model wears a dress from the A & F X Kemo Sabe collection. Photo courtesy of Abercrombie & Fitch According to Robinson, the partnership had organic beginnings. “A few summers ago, my family and I visited Kemo Sabe on vacation in Aspen. I’d been a fan for a few years. I was buying turquoise bracelet, and I met Wendy and our energy just clicked. She made my husband a hat and the kids got them too,” Robinson recalled. Shortly after Abercrombie & Fitch Co. CEO Fran Horowitz had visited the Park City, UT. “She immediately texted me to ask if I… The post Abercrombie & Fitch Goes Western With Kemo Sabe Brand Collaboration appeared on BitcoinEthereumNews.com. Models wearing the new A & F X Kemo Sabe collection. Photo Courtesy of Abercrombie & Fitch While the brand collaboration can be traced back to 1924 when Château Mouton Rothschild commissioned Jean Carlu to design a wine bottle label, the modern-day collaboration which merged when Nike teamed up with Commes Des Garcons, hit a pivotal moment when H&M released its first designer collaboration with Karl Lagerfeld. Since then, the mutual benefit that mass audience brands and specialty luxury brands can garner from one another is undeniable. Such is the case with a new partnership between Abercrombie & Fitch and Kemo Sabe, the cult-status luxury Western-centric accessories and outwear store that was founded in Aspen, CO. in 1990. The offering Abercrombie X Kemo Sabe offering, which features twelve women’s clothing styles and three accessories’ styles will launch October 30th on online at Abercrombie.com and all stores globally November 6th. The collection debuted in Manhattan a few weeks in advance to press at a presentation held at Common Country bar where Corey Robinson, chief product officer of Abercrombie & Fitch Co. and Wendy Kunkle, President and Owner of Kemo Sabe were on hand to discuss the unique pair up. A model wears a dress from the A & F X Kemo Sabe collection. Photo courtesy of Abercrombie & Fitch According to Robinson, the partnership had organic beginnings. “A few summers ago, my family and I visited Kemo Sabe on vacation in Aspen. I’d been a fan for a few years. I was buying turquoise bracelet, and I met Wendy and our energy just clicked. She made my husband a hat and the kids got them too,” Robinson recalled. Shortly after Abercrombie & Fitch Co. CEO Fran Horowitz had visited the Park City, UT. “She immediately texted me to ask if I…

Abercrombie & Fitch Goes Western With Kemo Sabe Brand Collaboration

Models wearing the new A & F X Kemo Sabe collection.

Photo Courtesy of Abercrombie & Fitch

While the brand collaboration can be traced back to 1924 when Château Mouton Rothschild commissioned Jean Carlu to design a wine bottle label, the modern-day collaboration which merged when Nike teamed up with Commes Des Garcons, hit a pivotal moment when H&M released its first designer collaboration with Karl Lagerfeld. Since then, the mutual benefit that mass audience brands and specialty luxury brands can garner from one another is undeniable.

Such is the case with a new partnership between Abercrombie & Fitch and Kemo Sabe, the cult-status luxury Western-centric accessories and outwear store that was founded in Aspen, CO. in 1990. The offering Abercrombie X Kemo Sabe offering, which features twelve women’s clothing styles and three accessories’ styles will launch October 30th on online at Abercrombie.com and all stores globally November 6th. The collection debuted in Manhattan a few weeks in advance to press at a presentation held at Common Country bar where Corey Robinson, chief product officer of Abercrombie & Fitch Co. and Wendy Kunkle, President and Owner of Kemo Sabe were on hand to discuss the unique pair up.

A model wears a dress from the A & F X Kemo Sabe collection.

Photo courtesy of Abercrombie & Fitch

According to Robinson, the partnership had organic beginnings. “A few summers ago, my family and I visited Kemo Sabe on vacation in Aspen. I’d been a fan for a few years. I was buying turquoise bracelet, and I met Wendy and our energy just clicked. She made my husband a hat and the kids got them too,” Robinson recalled.

Shortly after Abercrombie & Fitch Co. CEO Fran Horowitz had visited the Park City, UT. “She immediately texted me to ask if I knew the brand to which I replied, ‘I love it and know the owner,’” Robinson continued. The CEO agreed and the partnership was formalized in March.

“We have not done a true collaboration with a brand in a very, very, very long time. So, we’re going to be thoughtful about who we do this with, since this is not something we do often,” Robinson explained.

“Our customers are in 20s/30s, and they love Kemo Sabe and it has become a destination to buy a hat. Others will discover Kemo Sabe, a luxury brand, at relatively accessible price points,” Robinson said.

That said, for A&F it’s an elevated range with the limited-edition collection ranging from $50 to $500 for a natural leather jacket. It will be limited-edition and in select stores

A leather jacket from the A & F X Kemo Sabe collaboration.

Photo courtesy of Abercrombie & Fitch

“Typically, we offer vegan leather, and this is the first true leather jacket we have done in a while. It’s a higher price point for the A&F customer but still attainable,” Robinson noted. While A & F is known common as a ‘fleece’ brand some of the other best-sellers in the brand are dresses and denim which the collection offers. The latter will be available in both classic and Curve love cuts and product details such as authentic-finish studding, traditional ‘bug and wrinkle’ inspired stitching and embroidery. Though in just the right amount.

“I am not a big fan of too much embroidery. I want to have that dress for the rest of my life in my closet. I don’t want it to be out of style next year,” said Kurkle. The partnership marks the brand’s first global retail project.

With Kemo Sabe, A&F formed a true working partnership to create the product and the identity, working hand in hand to create what made sense. “What I’ve loved about working with Wendy is that she had a strong point of view from the beginning. There were some things where she was like, ‘Nope, we’re not doing that. It’s better work with a partner that has such a strong point of view is actually as a brand, it feels more authentic with having the handwriting of both brands on it,”

A model wear pieces of the A & F X Kemo Sabe collaboration collection.

Photo courtesy of Abercrombie & Fitch

“We’re high-end luxury western store, but when I say western, that’s a tricky word. Our brand aesthetic is fashion western than cowboy-inspired wear,” Kurkle continued. The Kemo Sabe customer is usually based in places such as Chicago, New York and Dallas ‘where they don’t actually dress in typical western styles.’ Her stores are located in Aspen, Vail, Park City, Utah, Round Top, Texas and Jackson Hole and Whitefish, both in Montana. In 2024 the brand did a pop up in New York City.

“We want this style to be accessible to people that wouldn’t normally wear it in the city, but now they do because we’ve introduced a higher-end version of Western that’s wearable, timeless and super classic,” she added noting that the Kemo Sabe customer is now looking at Abercrombie & Fitch for the first time in a while.

According to Robinson the collection will be in key locations such as Flatiron and Greenwich Avenue in New York and Lincoln Park in Chicago, Newbury Street in Boston, Westfield Century City in LA and Oxford Street in London. Robinson noted that the brand has moved away from the flagship prestige real estate strategy and meets the customer where they are at.

Western belt included in the A & F X Kemo Sabe collaboration.

Photos courtesy of Abercrombie & Fitch

Kurkle was drawn to the brand’s 130-year -old legacy. “That Abercrombie is American owned was unbelievable to me. Our factories are all in the states as well, and I just loved that heritage about them. I loved the people on their team and it’s a woman-led company. They used to be a hunting store and we’re from the West,” Kurkle enthused.

They also have another big thing in common. Each is infamous for having lines out the door. Kurkle lays it out this way. “We create a shopping experience that is pure joy at Kemo Sabe. Our goal is everybody should feel excitement when they come into our store. We serve free drinks; you can relax and meet amazing people. It’s crammed with people, dancing and yelling and it’s a lot of fun. We have lines out the door, people can wait 45 minutes to get in.”

Or they can hit up A&F for their next Kemo Sabe staples.

Source: https://www.forbes.com/sites/roxannerobinson/2025/10/30/abercrombie–fitch-goes-western-with-kemo-sabe-brand-collaboration/

Market Opportunity
SynFutures Logo
SynFutures Price(F)
$0.006748
$0.006748$0.006748
-0.57%
USD
SynFutures (F) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple!

Buterin unveils Ethereum’s strategy to tackle quantum security challenges ahead. Ethereum focuses on simplifying architecture while boosting security for users. Ethereum’s market stability grows as Buterin’s roadmap gains investor confidence. Ethereum founder Vitalik Buterin has unveiled his long-term vision for the blockchain, focusing on making Ethereum quantum-secure while maintaining its simplicity for users. Buterin presented his roadmap at the Japanese Developer Conference, and splits the future of Ethereum into three phases: short-term, mid-term, and long-term. Buterin’s most ambitious goal for Ethereum is to safeguard the blockchain against the threats posed by quantum computing.  The danger of such future developments is that the future may call into question the cryptographic security of most blockchain systems, and Ethereum will be able to remain ahead thanks to more sophisticated mathematical techniques to ensure the safety and integrity of its protocols. Buterin is committed to ensuring that Ethereum evolves in a way that not only meets today’s security challenges but also prepares for the unknowns of tomorrow. Also Read: Ethereum Giant The Ether Machine Takes Major Step Toward Going Public! However, in spite of such high ambitions, Buterin insisted that Ethereum also needed to simplify its architecture. An important aspect of this vision is to remove unnecessary complexity and make Ethereum more accessible and maintainable without losing its strong security capabilities. Security and simplicity form the core of Buterin’s strategy, as they guarantee that the users of Ethereum experience both security and smooth processes. Focus on Speed and Efficiency in the Short-Term In the short term, Buterin aims to enhance Ethereum’s transaction efficiency, a crucial step toward improving scalability and reducing transaction costs. These advantages are attributed to the fact that, within the mid-term, Ethereum is planning to enhance the speed of transactions in layer-2 networks. According to Butterin, this is part of Ethereum’s expansion, particularly because there is still more need to use blockchain technology to date. The other important aspect of Ethereum’s development is the layer-2 solutions. Buterin supports an approach in which the layer-2 networks are dependent on layer-1 to perform some essential tasks like data security, proof, and censorship resistance. This will enable the layer-2 systems of Ethereum to be concerned with verifying and sequencing transactions, which will improve the overall speed and efficiency of the network. Ethereum’s Market Stability Reflects Confidence in Long-Term Strategy Ethereum’s market performance has remained solid, with the cryptocurrency holding steady above $4,000. Currently priced at $4,492.15, Ethereum has experienced a slight 0.93% increase over the last 24 hours, while its trading volume surged by 8.72%, reaching $34.14 billion. These figures point to growing investor confidence in Ethereum’s long-term vision. The crypto community remains optimistic about Ethereum’s future, with many predicting the price could rise to $5,500 by mid-October. Buterin’s clear, forward-thinking strategy continues to build trust in Ethereum as one of the most secure and scalable blockchain platforms in the market. Also Read: Whales Dump 200 Million XRP in Just 2 Weeks – Is XRP’s Price on the Verge of Collapse? The post Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! appeared first on 36Crypto.
Share
Coinstats2025/09/18 01:22
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26